The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 18, 2020
Filed:
Apr. 06, 2016
Applicants:
Vavotar Life Sciences Llc, Cumming, GA (US);
Mayo Foundation for Medical Education and Research, Rochester, MN (US);
Inventors:
Gerald F. Swiss, Rancho Santa Fe, CA (US);
Svetomir N. Markovic, Rochester, MN (US);
Wendy K. Nevala, Rochester, MN (US);
Assignees:
Vavotar Life Sciences LLC, Cumming, GA (US);
Mayo Foundation for Medical Education and Research, Rochester, MN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/22 (2006.01); A61K 39/395 (2006.01); A61K 9/51 (2006.01); A61K 47/46 (2006.01); A61K 31/337 (2006.01); C07K 16/30 (2006.01); A61K 47/64 (2017.01); A61K 47/69 (2017.01); A61K 47/68 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 31/337 (2013.01); A61K 47/643 (2017.08); A61K 47/6803 (2017.08); A61K 47/6845 (2017.08); A61K 47/6929 (2017.08); C07K 16/22 (2013.01); C07K 16/30 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); A61K 2300/00 (2013.01); C07K 2317/24 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01);
Abstract
Described herein are methods, formulations and kits for treating a patient with cancer with anti-VEGF antibodies and albumin-bound chemotherapeutic/anti-VEGF antibody nanoparticle complexes.